Faecal Microbiota Transplantation for Microscopic Colitis
20 participantsStarted 2023-09
Plain-language summary
A pilot study investigating if orally administrated faecal microbiota transplantation capsules have the potential to treat active microscopic colitis.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of microscopic colitis
* Date of diagnosis/histological confirmation \< 12 months
* Active disease according to Hjortswang's criteria
Exclusion Criteria:
* Diagnosed with ulcerative colitis or Crohn's disease
* Diagnosed with celiac disease
* Active gastrointestinal infection
* Previous bowel resection of bowel (except appendectomy)
* Previous cholecystectomy
* Treatment with systemic steroid within 4 weeks, including budesonide
* Antibiotics 3 months prior
* Severe immunodeficiency,
* Pregnancy, planned pregnancy and breastfeeding
* Treatment with constipants such as psyllium, loperamide, bile binders, opium drops or codeine up to 2 weeks before inclusion and during participation